US9285634021 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 11.767B 8.84% | 12.851B 9.21% | 13.35B 3.88% | 14.02B 5.02% | ||||||||
EBITDA YoY % growth | 3.455B 44.38% | 3.498B 1.24% | 3.264B -6.69% | 5.006B 53.37% | N/A | N/A | N/A | N/A | N/A | |||
EBIT YoY % growth | 2.43B 59.87% | 2.388B -1.73% | 2.03B -14.99% | 3.912B 92.71% | N/A | N/A | N/A | N/A | N/A | |||
Operating Margin | 20.65% | 18.58% | 15.21% | 27.90% | N/A | N/A | N/A | N/A | N/A | |||
EPS YoY % growth | 7.20 11.46% | 7.25 0.69% | 6.52 -10.07% | 7.17 9.90% |
All data in USD
Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 1.76 19.63% | |||||||||
Revenue Q2Q % growth | 3.45B 7.44% | |||||||||
EBITDA Q2Q % growth | 1.268B | |||||||||
EBIT Q2Q % growth | 953.11M 144.39% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q2 2024 Q2Q % growth | 1.83 11.59% | 1.73 | 0.10 | 5.79% |
Q1 2024 Q2Q % growth | 1.49 16.41% | 1.58 | -0.09 | -5.43% |
Q4 2023 Q2Q % growth | 2.13 5.45% | 1.94 | 0.19 | 9.61% |
Q3 2023 Q2Q % growth | 1.47 -14.53% | 1.59 | -0.12 | -7.68% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q2 2024 Q2Q % growth | 3.408B 2.16% | 3.49B | -82M | -2.35% |
Q1 2024 Q2Q % growth | 3.277B 6.12% | 3.353B | -76M | -2.27% |
Q4 2023 Q2Q % growth | 3.715B 5.21% | 3.666B | 49M | 1.34% |
Q3 2023 Q2Q % growth | 3.211B 0.72% | 3.38B | -169M | -5.00% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0% | 5.95% | 0% | 2.55% |
Revenue | 0% | -0.35% | 0% | -0.66% |